Holen Sie sich die Stockscreener-App
33.78
40.37%
-22.87
Handel nachbörslich:
34.14
0.36
+1.07%
Schlusskurs vom Vortag:
$56.65
Offen:
$37.34
24-Stunden-Volumen:
92.94M
Relative Volume:
20.11
Marktkapitalisierung:
$27.62B
Einnahmen:
$163.07B
Nettoeinkommen (Verlust:
$3.31B
KGV:
5.4135
EPS:
6.24
Netto-Cashflow:
$-490.00M
1W Leistung:
-36.87%
1M Leistung:
-38.48%
6M Leistung:
-44.17%
1J Leistung:
-48.97%
1-Tages-Spanne:
$33.76
$37.78
1-Wochen-Bereich:
$33.76
$57.46
52-Wochen-Spanne:
$33.76
$80.59
Centene Corp Stock (CNC) Company Profile
Firmenname
Centene Corp
Sektor
Branche
Telefon
(314) 725-4477
Adresse
7700 FORSYTH BLVD., ST LOUIS
Vergleichen Sie CNC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CNC
Centene Corp
|
33.78 | 27.62B | 163.07B | 3.31B | -490.00M | 6.24 |
|
UNH
Unitedhealth Group Inc
|
307.56 | 275.58B | 410.06B | 22.11B | 24.86B | 23.88 |
|
ELV
Elevance Health Inc
|
350.25 | 86.74B | 183.12B | 5.92B | 3.67B | 25.63 |
|
CI
Cigna Group
|
320.39 | 82.87B | 254.47B | 5.03B | 6.01B | 18.06 |
|
CVS
Cvs Health Corp
|
66.60 | 81.29B | 378.96B | 5.28B | 5.94B | 4.19 |
|
HUM
Humana Inc
|
243.79 | 28.00B | 117.76B | 1.21B | 2.39B | 9.95 |
Centene Corp Stock (CNC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-09 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-06-02 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-04-08 | Hochstufung | Jefferies | Underperform → Hold |
| 2025-02-06 | Herabstufung | Argus | Buy → Hold |
| 2024-12-17 | Fortgesetzt | JP Morgan | Overweight |
| 2024-12-13 | Hochstufung | UBS | Neutral → Buy |
| 2024-12-10 | Herabstufung | Jefferies | Hold → Underperform |
| 2024-07-24 | Herabstufung | Jefferies | Buy → Hold |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Neutral |
| 2024-03-21 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2024-01-02 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-09-05 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-08-30 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-07-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2023-06-20 | Eingeleitet | UBS | Neutral |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-03-08 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-02-23 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-12-13 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-09-30 | Eingeleitet | Argus | Buy |
| 2022-08-26 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-07-28 | Fortgesetzt | Barclays | Overweight |
| 2022-07-14 | Hochstufung | Jefferies | Hold → Buy |
| 2022-06-21 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Fortgesetzt | Bernstein | Outperform |
| 2022-05-26 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-01-07 | Fortgesetzt | Barclays | Overweight |
| 2022-01-06 | Fortgesetzt | JP Morgan | Overweight |
| 2021-12-14 | Eingeleitet | Goldman | Neutral |
| 2021-12-13 | Bestätigt | BMO Capital Markets | Outperform |
| 2021-12-13 | Bestätigt | BofA Securities | Buy |
| 2021-12-13 | Bestätigt | Credit Suisse | Neutral |
| 2021-12-13 | Bestätigt | Mizuho | Neutral |
| 2021-12-13 | Bestätigt | Oppenheimer | Outperform |
| 2021-12-13 | Bestätigt | Stephens | Overweight |
| 2021-12-13 | Bestätigt | Truist | Buy |
| 2021-12-13 | Bestätigt | Wells Fargo | Overweight |
| 2021-12-13 | Bestätigt | Wolfe Research | Outperform |
| 2021-11-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Buy |
| 2021-05-19 | Eingeleitet | Wells Fargo | Overweight |
| 2021-05-11 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2021-03-10 | Eingeleitet | Mizuho | Neutral |
| 2021-01-21 | Fortgesetzt | Goldman | Neutral |
| 2021-01-15 | Herabstufung | Jefferies | Buy → Hold |
| 2020-09-22 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-07-01 | Eingeleitet | SVB Leerink | Outperform |
| 2020-02-05 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-02-03 | Fortgesetzt | Evercore ISI | Outperform |
| 2020-01-28 | Bestätigt | Bernstein | Outperform |
| 2020-01-06 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Buy |
| 2019-05-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2018-10-24 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-07-18 | Fortgesetzt | Citigroup | Neutral |
| 2017-12-18 | Bestätigt | Jefferies | Buy |
| 2017-09-13 | Bestätigt | Leerink Partners | Mkt Perform |
| 2017-06-07 | Eingeleitet | Morgan Stanley | Overweight |
| 2017-05-22 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2017-04-05 | Eingeleitet | Deutsche Bank | Buy |
| 2017-03-23 | Herabstufung | Citigroup | Buy → Neutral |
| 2017-02-08 | Bestätigt | Barclays | Overweight |
| 2017-02-07 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2017-01-04 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Centene Corp Aktie (CNC) Neueste Nachrichten
Is Centene Co. (NYSE:CNC) a Core Component of NYSE Composite Healthcare Services? - Kalkine Media
Should Value Investors Buy Centene (CNC) Stock? - Yahoo Finance
Morgan Stanley Sees 8.8% EPS CAGR for Centene (NYSE:CNC), Initiates Coverage with $70 target. - Insider Monkey
Morgan Stanley Initiates Centene (CNC) with Overweight Rating, Sets $70 PT - Insider Monkey
Centene’s SWOT analysis: stock faces challenges amid growth potential - Investing.com
Centene (CNC) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
Here's Why Centene (CNC) Could be Great Choice for a Bottom Fisher - Yahoo Finance
$1000 Invested In Centene 15 Years Ago Would Be Worth This Much Today - Benzinga
Centene Stock: Is CNC Outperforming The Health Care Sector? - Barchart.com
Centene Stock: Is CNC Outperforming the Health Care Sector? - The Globe and Mail
Centene (CNC) Initiated with Overweight Rating by Morgan Stanley | CNC Stock News - GuruFocus
Morgan Stanley Sees Upside for Centene (CNC) Despite Policy Chal - GuruFocus
Centene Co. (NYSE:CNC) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
July 25th Options Now Available For Centene (CNC) - Nasdaq
WellCare of Ky adds supports for communities hit by tornadoes - Lane Report
Zacks.com featured highlights StoneCo, Centene, CVS Health and Pfizer - Yahoo Finance
Centene Sees Unusually Large Options Volume (NYSE:CNC) - Defense World
Health Net Providing Special Assistance to Members and Providers Affected by Victoria Island Levee Incident in San Joaquin County, California - Quantisnow
Justice-Involved Individuals Reentering Society in Sacramento County Find a Place to Call Home Through a $2.6M Grant from Health Net to 'Break the Cycle' - Quantisnow
Centene Corp (CNC) Shares Down 3.3% on Jun 2 - GuruFocus
Barclays Downgrades Centene (CNC) on Policy Risk, Cuts Price Target to $65 - Insider Monkey
Centene (CNC) Target Price Cut by Barclays, Downgraded to Equal-Weight | CNC Stock News - GuruFocus
Breaking Down Centene: 5 Analysts Share Their Views - Benzinga
Barclays Lowers Centene (CNC) Stock Outlook Amid Concerns | CNC - GuruFocus
Are Investors Undervaluing Centene (CNC) Right Now? - Yahoo Finance
Health Net and Centene Corporation (CNC) Commit Over $7.2 Million to Boost Healthcare Access Through Mobile Clinics in California - Yahoo Finance
Health Net and Centene Foundation Invest More than $7.2 Million to Increase Patient Access to Care with Expanded Fleet of Mobile Clinics in California – Company AnnouncementFT.com - Financial Times
Zacks Investment Ideas feature highlights: Netflix, Eaton and Centene - The Globe and Mail
St. Louis’ Public Companies Show Strength - stl.news
Centene’s SWOT analysis: stock outlook amid healthcare sector challenges - Investing.com
House Advances Trump's 'One Big Beautiful Bill' After Key Medicaid, Tax, And Border Security Changes - Benzinga
Trump's 'Big Beautiful Bill' Advances: Here's Who Wins And Loses - Benzinga
The Zacks Analyst Blog Highlights UnitedHealth, Centene and Molina Healthcare - TradingView
Factors That Make Centene Stock a Lucrative Pick Right Now - Nasdaq
Trump's 'Big Beautiful Bill' Advances: Here's Who Wins And Loses - Benzinga
Zacks Value Trader Highlights: Centene, Copa and KB Financial - TradingView
Q1 Rundown: Centene (NYSE:CNC) Vs Other Health Insurance Providers Stocks - Yahoo Finance
Cantor Fitzgerald maintains Overweight on Centene shares, $90 target - Investing.com
Insider Stock Buying Reaches US$3.27m On Centene - Yahoo Finance
Screening for Basic Value Stocks - TradingView
Centene shareholders reject climate-related proposals in annual meeting vote - The Business Journals
Sarah London: Leading Women 2025 - Modern Healthcare
Sarah London named Modern Healthcare's Leading Women Vanguard - Modern Healthcare
Sarah London named Modern Healthcare’s Women Leaders Vanguard - Modern Healthcare
Centene Corporation (CNC) Announces Results of Annual Meeting - GuruFocus
Centene shareholders vote on key proposals at annual meeting - Investing.com
Here's Why Centene (CNC) is a Strong Value Stock - Yahoo Finance
Why Centene Corporation (CNC) Declined on Tuesday - Insider Monkey
Massive Sell-Offs Just Hit These 10 Stocks Today - Insider Monkey
Delaware First Health and the Centene Foundation Announce Grant Program Open Submission Period - Stock Titan
Finanzdaten der Centene Corp-Aktie (CNC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Centene Corp-Aktie (CNC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Greco Thomas | Director |
Dec 18 '24 |
Buy |
59.75 |
17,000 |
1,015,750 |
19,309 |
| Dallas H James | Director |
Dec 16 '24 |
Buy |
59.01 |
1,693 |
99,904 |
1,693 |
| BLUME JESSICA L. | Director |
Dec 16 '24 |
Buy |
59.48 |
250 |
14,870 |
250 |
| COUGHLIN CHRISTOPHER J | Director |
Dec 16 '24 |
Buy |
59.44 |
10,000 |
594,400 |
36,358 |
| Samuels Theodore R. II | Director |
Dec 13 '24 |
Buy |
58.86 |
5,000 |
294,300 |
23,000 |
| Asher Andrew Lynn | Chief Financial Officer |
Nov 13 '24 |
Buy |
58.14 |
17,200 |
1,000,008 |
486,847 |
| LONDON SARAH | Chief Executive Officer |
Nov 08 '24 |
Buy |
60.80 |
4,117 |
250,314 |
667,229 |
3.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):